Abstract
The prevalence of thyroid dysfunction varies in different populations. The aim of this cross-sectional study was to analyze the prevalence of undiagnosed thyroid dysfunction and thyroid antibodies and their relationship with urine iodine excretion in a representative sample of 1,124 (55.5% women; mean age: 44.8 ± 15.2 years) non-hospitalized Mediterranean adults, in Catalonia (Spain). Free thyroxine, thyroid-stimulating hormone, thyroperoxidase and thyroglobulin antibodies, and urine iodine were measured. Undiagnosed thyroid dysfunction was 5.3% (hypothyroidism 3.8%; 56.66% of these subjects were women). The total (diagnosed + undiagnosed) thyroid dysfunction was 8.9% (71.15% women). Thyroperoxidase antibodies were positive in 2.4% of men and 9.4% of women and thyroglobulin antibodies, in 1.3% of men and 3.8% of women. No differences were observed in urine iodine between groups with thyroid dysfunction and euthyroidism, or between subjects with positive or negative antibodies. In subjects over 60, undiagnosed thyroid dysfunction was 9.8% (hypothyroidism 6.9%, hyperthyroidism 3.3%; 36.36% women) and total thyroid dysfunction 13.61% (53.12% women). Women and men over 60 had similar thyroid dysfunction prevalence. Thus, aggressive case-finding should be recommended in both, over 60.
Similar content being viewed by others
References
S.H. Golden, K.A. Robinson, I. Saldanha, B. Anton, P.W. Ladenson, Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J. Clin. Endocrinol. Metab. 94, 1853–1878 (2009)
M.I. Surks, E. Ortiz, G.H. Daniels, C.T. Sawin, N.F. Col, R.H. Cobin, J.A. Franklyn, J.M. Hershman, K.D. Burman, M.A. Denke, C. Gorman, R.S. Cooper, N.J. Weissman, Subclinical thyroid disease. Scientific review and guidelines for diagnosis and management. JAMA 291, 228–238 (2004)
M. Helfand, Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the US Preventive Services Task Force. Ann. Intern. Med. 140, 128–141 (2004)
J.J. Corrales Hernández, N. Alonso Pedrol, A. Cantón Blanco, J.C. Galofré Ferrater, A. Pérez Pérez, T. Lajo Morales, B. Pérez Corral, F. Tortosa Henzi, Guía clínica del diagnóstico y tratamiento de la disfunción tiroidea subclínica. (Clinical practice guideline for the diagnosis and treatment of subclinical thyroid disease). Endocrinol. Nutr. 54, 44–52 (2007)
P. Haentjens, A. Meerhaeghe, K. Poppe, B. Velkeniers, Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies. Eur. J. Endocrinol. 159, 329–341 (2008)
N. Ochs, R. Auer, C. Bauer, D. Nanchen, J. Gussekloo, J. Cornuz, N. Rodondi, Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann. Intern. Med. 148, 832–845 (2008)
B. Biondi, D.S. Cooper, The clinical significance of subclinical thyroid dysfunction. Endocr. Rev. 20, 76–131 (2008)
V. Fatourechi, Subclinical hypothyroidism: an update for primary physicians. Mayo Clin. Proc. 84, 65–71 (2009)
J.G. Hollowell, N.W. Staehling, W.D. Flanders, W.H. Hannon, E.W. Gunter, C.A. Spencer, E.L. Braverman, Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 87, 489–499 (2002)
W.M. Tunbridge, D.C. Evered, R. Hall, D. Appleton, M. Brewis, F. Clark, J. Grimley, J. Evans, E. Young, T. Bird, P.A. Smith, The spectrum of thyroid disease in a community: the Whickham Survey. Clin. Endocrinol. (Oxf) 7, 481–493 (1977)
M.P.J. Vanderpump, W.M.G. Tunbridge, Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid 12, 839–847 (2002)
P. Valeix, C. Dos Santos, K. Castetbon, S. Bertrais, C. Cousty, S. Hercberg, Statut thyroïdien et fréquences des dysthyroïdies chez les adultes inclus dans l’étude SU.VI.MAX en 1994–1995. [Thyroid hormone levels and thyroid dysfunction of French adults participating in the SU.VI.MAX. study (1994–1995)]. Ann. Endocrinol. (Paris) 65, 477–486 (2004)
T. Bjoro, J. Holmen, O. Krüger, K. Midthjell, K. Hunstad, T. Schreiner, L. Sandnes, H. Brochmann, Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). Eur. J. Endocrinol. 143, 639–647 (2000)
G.J. Canaris, N.R. Manowitz, G. Mayor, E.C. Ridgway, The Colorado thyroid disease prevalence study. Arch. Intern. Med. 160, 526–534 (2000)
P.C. O’Leary, P.H. Feddema, V.P. Michelangeli, P.J. Leedman, G.T. Chew, M. Knuiman, J. Kaye, J.P. Walsh, Investigations of thyroid hormones and antibodies based on a community health survey: the Busselton thyroid study. Clin. Endocrinol. (Oxf) 64, 97–104 (2006)
N. Konno, H. Makita, K. Yuri, N. Iizuka, K. Kawasaki, Association between dietary iodine intake and prevalence of subclinical hypothyroidism in the coastal regions of Japan. J. Clin. Endocrinol. Metab. 78, 393–397 (1994)
N. Knudsen, T. Jorgensen, S. Rasmussen, E. Christiansen, H. Perrild, The prevalence of thyroid dysfunction in a population with borderline iodine deficiency. Clin. Endocrinol. (Oxf) 51, 361–367 (1999)
F. Aghini-Lombardi, L. Antonangeli, E. Martino, P. Vitti, D. Maccherini, F. Leoli, T. Rago, L. Grasso, R. Valeriano, A. Balestrieri, A. Pinchera, The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano Survey. J. Clin. Endocrinol. Metab. 84, 561–566 (1999)
N. Konno, K. Yuri, H. Taguchi, K. Miura, S. Taguchi, K. Hagiwara, S. Murakami, Screening for thyroid diseases in an iodine sufficient area with sensitive thyrotrophin assays, and serum thyroid autoantibody and urinary iodide determinations. Clin. Endocrinol. 38, 273–281 (1993)
A. Alsayed, A.M. Gad, H. Abdel-Baset, A. Abdel-Fattah, A. Ahmed, A. Azab, Excess urinary iodine is associated with autoimmune subclinical hypothyroidism among Egyptian women. Endocr. J. 55, 601–605 (2008)
P. Laurberg, C. Cerqueira, L. Ovesen, L.B. Rasmussen, H. Perrild, S. Andersen, I.B. Pedersen, A. Carlé, Iodine intake as a determinant of thyroid disorders in populations. Best. Pract. Res. Clin. Endocrinol. Metab. 24, 13–27 (2010)
S. Juncà, M. Guillén, J.M. Aragay, P. Brugulat, C. Castell, E. Séculi, A. Medina, R. Tresserras, Aspectos metodológicos de la evaluación de los objetivos de salud y disminución de riesgo del Plan de Salud de Cataluña para el año 2000. (Methodological aspects in the evaluation of health and risk-reduction objectives of Health Plan for Catalonia for the year 2000). Med. Clin. (Barc) 121, 10–19 (2003)
P.S. Levy, S. Lemeshow, Sampling of Populations: Methods and Applications, 3rd edn. (Wiley, New York, 1999)
L. Salleras, R. Tresserras, Evaluación de los objetivos del Plan de Salud de Cataluña para el año 2000. (Decade assessment. Summary of evaluation of the objectives of the Health Plan for Catalonia for the year 2000). Med. Clin. (Barc) 121, 1–142 (2003)
S. Wilson, J.V. Parle, L.M. Roberts, A.K. Roalfe, F.D. Hobbs, P. Clark, M.C. Sheppard, M.D. Gammage, H.M. Pattison, J.A. Franklyn, Birmingham Elderly Thyroid Study Team, Prevalence of subclinical thyroid dysfunction and its relation to socioeconomic deprivation in the elderly: a community-based cross-sectional survey. J. Clin. Endocrinol. Metab. 91, 4809–4816 (2006)
J.J. Díez, I. Molina, M.T. Ibars, Prevalence of thyroid dysfunction in adults over age 60 years from an urban community. Exp. Clin. Endocrinol. Diab. 111, 480–485 (2003)
M.J. Sender Palacios, M. Vernet Vernet, S. Pérez López, M. Faro Colomés, M. Rojas Blanc, L. Pallisa Gabriel, Enfermedad funcional tiroidea en la población de edad avanzada. (Functional thyroid pathology in the elderly). Aten. Primaria 34, 192–197 (2004)
M.I. Surks, J.G. Hollowell, Age-specific distribution of serum thyrotropin and thyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 92, 4575–4582 (2007)
E.H. Hoogendoorn, A.R. Hermus, F. de Vegt, H.A. Ross, A.L. Verbeek, L.A. Kiemeney, D.W. Swinkels, F.C. Sweep, M. den Heijer, Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin. Chem. 52, 104–111 (2006)
F. Delange, B. de Benoist, H. Burgi, Determining median urinary iodine concentration that indicates adequate iodine intake at population level. Bull. World Health Organ. 80, 633–636 (2002)
J.E. Haddow, M.R. McClain, G.E. Palomaki, J.G. Hollowell, Urine iodine measurements, creatinine adjustment, and thyroid deficiency in an adult United States population. J. Clin. Endocrinol. Metab. 92, 1019–1022 (2007)
A. Tomer, T.F. Davies, Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr. Rev. 24, 694–717 (2003)
M. Empson, V. Flood, G. Ma, C.J. Eastman, P. Mitchell, Prevalence of thyroid disease in an older Australian population. Intern. Med. J. 37, 448–455 (2007)
Acknowledgments
The authors thank Anna Sanmartí for her aid during the study development, manuscript revision, and general support; and Christine O’Hara for valuable assistance in language revision.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lucas, A., Julián, M.T., Cantón, A. et al. Undiagnosed thyroid dysfunction, thyroid antibodies, and iodine excretion in a Mediterranean population. Endocr 38, 391–396 (2010). https://doi.org/10.1007/s12020-010-9397-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-010-9397-2